Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2677 of 5804
-
Zoom bike workouts could help young brain tumor survivors get fit and think sharper
Symptom relief Recruiting nowThe purpose of this study is to determine whether a 16-week virtual, home-based, high-intensity interval training (HIIT) exercise program will improve physical, cognitive, and emotional health among young adult survivors of pediatric brain tumors. The names of the study interven…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo targets rare blood cancers
Disease control Recruiting nowThis study is being conducted to evaluate the safety, tolerability, dose-limiting toxicity (DLT) and determine the maximum tolerated dose (MTD) and/or recommended dose(s) for expansion (RDE) of INCA033989 administered as a Monotherapy or in Combination With Ruxolitinib in partici…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Fake-Fast diet may soothe gum treatment side effects
Symptom relief CompletedPeriodontitis (gum disease) leads to the formation of gum pockets. Its treatment involves deep cleaning of the teeth, to remove soft and hard tooth deposits under the gum line. Although in the long term this leads to improvement of the gum conditions and reduced inflammation, in …
Phase: NA • Sponsor: Universitat Internacional de Catalunya • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Arm access may be safer for heart valve patients, major trial launches
Knowledge-focused Recruiting nowTranscatheter aortic valve implantation (TAVI) is a well-known safe and effective treatment for anatomically suitable patients with severe aortic stenosis (AS). Despite rapid improvements in TAVI technique and technology, vascular and bleeding complications from both primary and …
Phase: NA • Sponsor: The Alfred • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New cancer drug combo enters first human tests
Disease control OngoingThe goal of this first in human clinical trial is to test BI-1910 administered as single agent and in combination with pembrolizumab in subjects with advanced/metastatic solid tumors whose disease has progressed after standard therapy. The main questions it aims to answer are: …
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Jun 26, 2026 19:03 UTC
-
App aims to keep HIV patients with addiction on track
Disease control OngoingThe current protocol aims to enroll up to 806 participants from 8 study sites in a clinic-supported intervention which will connect them to Vivent Health care team and a cohort of peer mentors for a year-long intervention period to support patient HIV care to maintain viral suppr…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug shows promise for rare muscle disease
Disease control CompletedThe primary efficacy objective: To evaluate the effect of daxdilimab compared with placebo in reducing disease activity at Week 24. The secondary efficacy objectives include: 1. To evaluate the effect of daxdilimab compared with placebo in reducing disease activity at Week 24.…
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Jail-based counseling aims to cut substance-exposed pregnancies
Prevention Recruiting nowThe goal of this pilot trial is to test the feasibility and acceptability as well as efficacy of the adapted intervention, CHOICES-PLEAS (Pregnancy Liberated from Exposure to Alcohol and Substances) among women will illicit polysubstance use participating in a court-mandated jail…
Phase: NA • Sponsor: St. Louis University • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
Wireless brain implant could revolutionize epilepsy monitoring
Disease control OngoingThe present study is a 13 months pre-market open-label, prospective study for confirmation of continuous performance and safety of UNEEG EpiSight solution in subjects with uncontrolled epilepsy (indicated for EEG monitoring with the Implant) in which seizures are detectable in an…
Phase: NA • Sponsor: UNEEG Medical A/S • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a single rinse replace antibiotic cocktails in penile implant surgery?
Disease control OngoingThe purpose of this study is to assess whether intraoperative irrigation with Irrisept is not inferior to irrigation with multiple antibiotics during placement of a first time inflatable penile prosthesis device.
Phase: PHASE3 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Herbal drink shows promise for prediabetes blood sugar control
Disease control CompletedThe goal of this two arms, randomized, double-blind controlled trial is to study whether Nutrilite herbal drink could ameliorate blood glucose level in prediabetes population. 100 eligible Participants aged 18-65 years will be enrolled in one center. Participants will be randoml…
Phase: NA • Sponsor: Amway (China) R&D Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can VR headsets ease chronic pain? new pilot study explores
Symptom relief CompletedThis pilot study aims to evaluate the integration of virtual reality (VR) with a psychoeducational program for individuals experiencing chronic pain and central sensitization. Chronic pain significantly hampers daily life, and the condition of central sensitization intensifies th…
Phase: NA • Sponsor: Badalona Serveis Assistencials • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Starting preschool at age 3: a boost for kids and moms in kenya?
Knowledge-focused CompletedThis research project aims to design and evaluate an innovative model for childcare provision in rural Kenya that emphasizes child development and economic participation for women in a cost-effective manner. Using a randomized controlled trial (RCT) design, the project will exami…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Which exercise helps kids bounce back after leukemia? new study tests two approaches
Symptom relief CompletedThis study compared the effects of constant-load aerobic exercise (CL-AEx) and graded aerobic exercise (G-AEx) on cardiopulmonary fitness and functional capacity in pediatric survivors of acute lymphoblastic leukemia (ALL). A cohort of 72 pediatric ALL survivors was randomly ass…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Sleep school: a new hope for chronic insomnia sufferers?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn about insomnia treatment among primary care patients with chronic insomnia. The main question it aims to answer is: • Does Sleep School (a therapy for insomnia) work well to decrease harm of insomnia? Participants will attend a group …
Phase: NA • Sponsor: University of Turku • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New drug aims to tame antibodies in rare clotting disorder
Disease control CompletedThe purpose of this study is to evaluate the regulatory effect of Telitacicept on antibody titers in primary antiphospholipid syndrome patients carrying high-risk antiphospholipid antibody profiles.
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for advanced cancers: experimental drug XNW28012 enters human trials
Disease control Recruiting nowThis is an open-label, dose escalation, multicenter, phase 1, first-in-human study of XNW28012 in subjects with advanced solid tumors who have failed current standard anti-tumor therapies or are intolerant to such therapies. The study consists of two parts: a dose escalation part…
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Bone graft and drug combo may bolster hip fracture repair in osteoporosis patients
Disease control CompletedThe goal of this clinical trial is to investigate the new bone formation around a metal device in the femoral head in patients with osteoporotic hip fractures undergoing surgical treatment with nails. These surgeries have a high risk of fixation failure in patients with osteoporo…
Phase: PHASE4 • Sponsor: Aksaray University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New antibody aimed at ARDS shows promise in early trial
Disease control OngoingA Phase 2a, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of ALT-100mAb in patients with moderate to severe ARDS.
Phase: PHASE2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Digital health trial tests home monitoring for seniors in taiwan
Disease control CompletedThis study aims to evaluate the effectiveness of a digital health intervention for community-dwelling middle-aged and older adults in Taiwan. A total of 199 participants from four randomly selected communities will be enrolled in a 6-month cluster randomized trial. Participants i…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC